HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

CXCR2 expression in tumor cells is a poor prognostic factor and promotes invasion and metastasis in lung adenocarcinoma.

Abstract
CXCR2 in non-small cell lung cancer (NSCLC) has been studied mainly in stromal cells and is known to increase tumor inflammation and angiogenesis. Here, we examined the prognostic importance of CXCR2 in NSCLC and the role of CXCR2 and its ligands in lung cancer cells. The effect of CXCR2 expression on tumor cells was studied using stable knockdown clones derived from a murine KRAS/p53-mutant lung adenocarcinoma cell line with high metastatic potential and an orthotopic syngeneic mouse model and in vitro using a CXCR2 small-molecule antagonist (SB225002). CXCR2 protein expression was analyzed in tumor cells from 262 NSCLC. Gene expression profiles for CXCR2 and its ligands (CXCR2 axis) were analyzed in 52 human NSCLC cell lines and 442 human lung adenocarcinomas. Methylation of CXCR2 axis promoters was determined in 70 human NSCLC cell lines. Invasion and metastasis were decreased in CXCR2 knockdown clones in vitro and in vivo. SB225002 decreased invasion in vitro. In lung adenocarcinomas, CXCR2 expression in tumor cells was associated with smoking and poor prognosis. CXCR2 axis gene expression profiles in human NSCLC cell lines and lung adenocarcinomas defined a cluster driven by CXCL5 and associated with smoking, poor prognosis, and RAS pathway activation. Expression of CXCL5 was regulated by promoter methylation. The CXCR2 axis may be an important target in smoking-related lung adenocarcinoma.
AuthorsPierre Saintigny, Erminia Massarelli, Steven Lin, Young-Ho Ahn, Yulong Chen, Sangeeta Goswami, Baruch Erez, Michael S O'Reilly, Diane Liu, J Jack Lee, Li Zhang, Yuan Ping, Carmen Behrens, Luisa M Solis Soto, John V Heymach, Edward S Kim, Roy S Herbst, Scott M Lippman, Ignacio I Wistuba, Waun Ki Hong, Jonathan M Kurie, Ja Seok Koo
JournalCancer research (Cancer Res) Vol. 73 Issue 2 Pg. 571-82 (Jan 15 2013) ISSN: 1538-7445 [Electronic] United States
PMID23204236 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Receptors, Interleukin-8B
Topics
  • Adenocarcinoma (diagnosis, metabolism, pathology)
  • Adenocarcinoma of Lung
  • Animals
  • Cell Line, Tumor
  • DNA Methylation
  • Gene Knockdown Techniques
  • Humans
  • Lung Neoplasms (diagnosis, metabolism, pathology)
  • Mice
  • Neoplasm Invasiveness
  • Neoplasm Metastasis
  • Prognosis
  • Receptors, Interleukin-8B (genetics, metabolism)
  • Smoking

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: